000 01259 a2200361 4500
005 20250516190133.0
264 0 _c20140804
008 201408s 0 0 eng d
022 _a1740-2530
024 7 _a10.1155/2013/310628
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Jiangtao
245 0 0 _aEfficacy and safety of iguratimod for the treatment of rheumatoid arthritis.
_h[electronic resource]
260 _bClinical & developmental immunology
_c2013
300 _a310628 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aArthritis, Rheumatoid
_xdiagnosis
650 0 4 _aChromones
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aOdds Ratio
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSulfonamides
_xadverse effects
650 0 4 _aTreatment Outcome
700 1 _aMao, Hejuan
700 1 _aLiang, Yan
700 1 _aLu, Yanrong
700 1 _aChen, Shuo
700 1 _aYang, Nanping
700 1 _aShi, Guixiu
773 0 _tClinical & developmental immunology
_gvol. 2013
_gp. 310628
856 4 0 _uhttps://doi.org/10.1155/2013/310628
_zAvailable from publisher's website
999 _c23398766
_d23398766